[go: up one dir, main page]

DE69835438D1 - Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene - Google Patents

Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene

Info

Publication number
DE69835438D1
DE69835438D1 DE69835438T DE69835438T DE69835438D1 DE 69835438 D1 DE69835438 D1 DE 69835438D1 DE 69835438 T DE69835438 T DE 69835438T DE 69835438 T DE69835438 T DE 69835438T DE 69835438 D1 DE69835438 D1 DE 69835438D1
Authority
DE
Germany
Prior art keywords
pathogene
targeting
photo
sensitivity
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69835438T
Other languages
English (en)
Other versions
DE69835438T2 (de
Inventor
Tayyaba Hasan
R Hamblin
Nikos Soukos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE69835438D1 publication Critical patent/DE69835438D1/de
Application granted granted Critical
Publication of DE69835438T2 publication Critical patent/DE69835438T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69835438T 1997-03-06 1998-02-27 Photo-empfindlichkeit-erhöhende konjugate zur targeting von pathogene Expired - Fee Related DE69835438T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US812606 1997-03-06
US08/812,606 US6462070B1 (en) 1997-03-06 1997-03-06 Photosensitizer conjugates for pathogen targeting
PCT/US1998/004001 WO1998039011A1 (en) 1997-03-06 1998-02-27 Photosensitizer conjugates for pathogen targeting

Publications (2)

Publication Number Publication Date
DE69835438D1 true DE69835438D1 (de) 2006-09-14
DE69835438T2 DE69835438T2 (de) 2007-03-15

Family

ID=25210103

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835438T Expired - Fee Related DE69835438T2 (de) 1997-03-06 1998-02-27 Photo-empfindlichkeit-erhöhende konjugate zur targeting von pathogene

Country Status (10)

Country Link
US (2) US6462070B1 (de)
EP (1) EP1017397B1 (de)
JP (1) JP2001513819A (de)
KR (1) KR20000076016A (de)
CN (1) CN1255063A (de)
AT (1) ATE334676T1 (de)
AU (1) AU737574B2 (de)
CA (1) CA2283868C (de)
DE (1) DE69835438T2 (de)
WO (1) WO1998039011A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462070B1 (en) * 1997-03-06 2002-10-08 The General Hospital Corporation Photosensitizer conjugates for pathogen targeting
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
DE19827417B4 (de) * 1998-06-19 2004-10-28 Hahn, Rainer, Dr.Med.Dent. Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen
US7015309B1 (en) 1999-06-23 2006-03-21 The Wistar Institute Of Anatomy And Biology Pyrrhocoricin-derived peptides, and methods of use thereof
US20020169107A1 (en) * 2001-01-19 2002-11-14 Mallinckrodt Inc. Novel aromatic azides for type I phototherapy
US7235685B2 (en) * 2001-07-03 2007-06-26 Mallinckrodt, Inc. Aromatic sulfenates for type I phototherapy
EP1252517A4 (de) * 2000-01-21 2004-10-20 Wistar Inst Biozidmoleküle, makromolekulare ziele und verfahren zur herstellung und verwendung
EP1272119B1 (de) * 2000-02-11 2010-11-24 The General Hospital Corporation Photochemische gewebeverbindung
US7090497B1 (en) * 2001-02-21 2006-08-15 Harris David M Method of periodontal laser treatment
GB0120022D0 (en) 2001-08-16 2001-10-10 Photobiotics Ltd Conjugate
US6558653B2 (en) * 2001-09-19 2003-05-06 Scot N. Andersen Methods for treating periodontal disease
US20040127892A1 (en) * 2002-01-31 2004-07-01 Harris David M. Periodontal laser and methods
NL1020336C2 (nl) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Toepassing van een verbinding voor de bereiding van een farmaceutisch preparaat voor het behandelen van brandwonden, en een werkwijze voor het behandelen van brandwonden.
US20040052798A1 (en) * 2002-09-12 2004-03-18 Ceramoptec Industries, Inc. Microbe reduction in the oral cavity with photosensitizers
WO2004044191A1 (en) * 2002-11-14 2004-05-27 Novartis Ag Antimicrobial activity of antibodies producing reactive oxygen species
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
KR101277022B1 (ko) * 2004-08-06 2013-06-24 파로스 라이프 코오포레이션 치료기와 관련 액세서리, 조성물 및 치료방법
US20060047281A1 (en) 2004-09-01 2006-03-02 Syneron Medical Ltd. Method and system for invasive skin treatment
AU2006283726C1 (en) 2005-08-24 2015-05-07 Immunogen, Inc. Process for preparing maytansinoid antibody conjugates
EP1933941A2 (de) 2005-08-25 2008-06-25 Philip R. Houle Behandlungssysteme zur abgabe von sensibilisatorlösungen
CA113237S (en) 2005-10-26 2009-07-15 John Kennedy Phototherapy device
US20100016208A1 (en) * 2005-11-15 2010-01-21 The General Hospital Corporation Photoactivatable antimicrobial agents
CA2535276A1 (en) * 2006-02-06 2007-08-06 John Kennedy Therapy device and system and method for reducing harmful exposure to electromagnetic radiation
AU2006341380B2 (en) * 2006-03-31 2013-01-10 Emory University Light activated antiviral materials and devices and methods for decontaminating virus infected environments
BRPI0714667A8 (pt) * 2006-07-27 2016-10-18 Ceramoptec Ind Inc Conjugado molecular e respectivo uso
US20090030257A1 (en) * 2007-07-25 2009-01-29 Ceramoptec Industries Inc. Anti-microbial photodynamic therapy
DK2244724T3 (en) * 2008-01-07 2015-06-29 Rapid Pathogen Screening Inc Use of peptides for promoting wound healing
US9090670B2 (en) 2008-01-07 2015-07-28 Rapid Pathogen Screening, Inc. Use of peptides for promoting wound healing
MX2010007860A (es) 2008-01-17 2010-11-30 Syneron Medical Ltd Un aparato de eliminacion de vello para uso personal y metodo para usarlo.
WO2009093230A2 (en) 2008-01-24 2009-07-30 Syneron Medical Ltd. A device, apparatus, and method of adipose tissue treatment
WO2009137062A2 (en) 2008-05-05 2009-11-12 The General Hospital Corporation Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same
US20100017750A1 (en) 2008-07-16 2010-01-21 Avner Rosenberg User interface
US9314293B2 (en) 2008-07-16 2016-04-19 Syneron Medical Ltd RF electrode for aesthetic and body shaping devices and method of using same
WO2010014728A1 (en) 2008-07-29 2010-02-04 Frontier Scientific Inc. Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth
US8859760B2 (en) 2008-07-29 2014-10-14 Frontier Scientific, Inc. Compositions for killing or preventing the growth of microbes
BRPI0917921A2 (pt) 2008-09-21 2015-11-10 Syneron Medical Ltd método e aparelho para tratamento de pele pessoal
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
US9278230B2 (en) 2009-02-25 2016-03-08 Syneron Medical Ltd Electrical skin rejuvenation
SI2437790T1 (sl) 2009-06-03 2019-07-31 Immunogen, Inc. Konjugacijske metode
EP2506773B1 (de) 2009-12-06 2018-08-15 Syneron Medical Ltd. Vorrichtung zur hautpflege
MX339927B (es) 2011-03-29 2016-06-16 Immunogen Inc Preparacion de conjugados de maitansinoides y anticuerpos mediante un proceso de una etapa.
KR101385196B1 (ko) * 2012-05-17 2014-04-14 주식회사 유니크메디케어 광 조사를 이용한 광감각제―펩타이드를 유효성분으로 포함하는 발모 개선 또는 촉진용 조성물 및 이를 이용한 방법
US20130310326A1 (en) 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
JP2015522554A (ja) 2012-06-04 2015-08-06 サンコー・エナジー・インコーポレーテッド パラフィン油及び沈降防止剤を含む製剤
WO2013192521A1 (en) * 2012-06-22 2013-12-27 The General Hospital Corporation β-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION
WO2014004680A1 (en) * 2012-06-26 2014-01-03 University Of Rochester Catheter/stent system for activation of photodynamic therapy within the catheter/stent system
NZ707091A (en) 2012-10-04 2018-12-21 Immunogen Inc Use of a pvdf membrane to purify cell-binding agent cytotoxic agent conjugates
US9581594B2 (en) 2013-03-14 2017-02-28 The United States Of America, As Represented By The Secretary Of The Navy Porphyrin—modified antimicrobial peptides for application as indicators of microbial targets
WO2014159904A1 (en) * 2013-03-14 2014-10-02 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Porphyrin-modified antimicrobial peptides for application as indicators of microbial targets
US20160286801A1 (en) 2013-03-15 2016-10-06 Suncor Energy Inc. Herbicidal Compositions
US12109429B2 (en) 2015-07-28 2024-10-08 Know Bio, Llc Phototherapeutic light for treatment of pathogens
US10569097B2 (en) 2015-07-28 2020-02-25 Photonmd, Inc. Systems and methods for phototherapeutic modulation of nitric oxide
CN107648587A (zh) * 2017-10-23 2018-02-02 安徽科技学院 抗菌肽以及融合蛋白在制备治疗幽门螺旋杆菌病的药物中的应用
CN108588093A (zh) * 2018-04-11 2018-09-28 湖南文理学院 东方铃蟾肠道芽孢杆菌表达蛋白对泌乳奶牛粪便具有强除臭能力的ness1-a基因
US12138308B2 (en) 2018-09-20 2024-11-12 Enbiar Inc. Polymer composite for helicobacter pylori recognition and composition for photodynamic therapy comprising same
JP7168770B2 (ja) * 2018-09-20 2022-11-09 エンビアル インコーポレイテッド ヘリコバクター・ピロリ認知用高分子複合体及びそれを含む光線力学治療用組成物
JP7588289B2 (ja) 2019-02-15 2024-11-22 ニュートリエン・エージー・ソリューションズ・（カナダ）・インコーポレイテッド 植物の健康を増進するプロトポルフィリンｉｘ誘導体及びその使用
US12447354B2 (en) 2020-03-19 2025-10-21 Know Bio, Llc Illumination devices for inducing biological effects
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US12011611B2 (en) 2020-03-19 2024-06-18 Know Bio, Llc Illumination devices for inducing biological effects
US11986666B2 (en) 2020-03-19 2024-05-21 Know Bio, Llc Illumination devices for inducing biological effects
US12347337B2 (en) 2020-12-10 2025-07-01 Know Bio, Llc Enhanced testing and characterization techniques for phototherapeutic light treatments
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices
US12115384B2 (en) 2021-03-15 2024-10-15 Know Bio, Llc Devices and methods for illuminating tissue to induce biological effects

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
EP0349578B2 (de) 1987-03-02 1998-10-28 Enzon Labs Inc. Organismus als Träger für "Single Chain Antibody Domain (SCAD)".
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5198346A (en) 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5041078A (en) * 1989-03-06 1991-08-20 Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas Photodynamic viral deactivation with sapphyrins
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
WO1992014493A1 (en) * 1991-02-20 1992-09-03 Christopher Capelli Non-protein intracellular receptor binding conjugates and a method of use thereof
US5486503A (en) 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
US6462070B1 (en) * 1997-03-06 2002-10-08 The General Hospital Corporation Photosensitizer conjugates for pathogen targeting
JP2001510773A (ja) * 1997-07-28 2001-08-07 ダーマトレイザー テクノロジーズ リミテッド 光線療法に基づく病原体の治療方法及びそれを達成するための組成物

Also Published As

Publication number Publication date
EP1017397A4 (de) 2004-06-16
US6462070B1 (en) 2002-10-08
CA2283868C (en) 2008-05-06
CN1255063A (zh) 2000-05-31
AU737574B2 (en) 2001-08-23
US7268155B2 (en) 2007-09-11
US20020183245A1 (en) 2002-12-05
CA2283868A1 (en) 1998-09-11
WO1998039011A1 (en) 1998-09-11
DE69835438T2 (de) 2007-03-15
ATE334676T1 (de) 2006-08-15
EP1017397A1 (de) 2000-07-12
AU6676798A (en) 1998-09-22
KR20000076016A (ko) 2000-12-26
EP1017397B1 (de) 2006-08-02
JP2001513819A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
DE69835438D1 (de) Photo-empfindlichkeit-erhöhende conjugate zur targeting von pathogene
CY1111832T1 (el) Φθαλοκυανινες ψευδαργυρου και τα αντιστοιχα συζυγη, η παρασκευη αυτων και η χρηση στην φωτοδυναμικη θεραπεια και ως διαγνωστικοι παραγοντες
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
EA200100838A1 (ru) Конъюгаты гксф
WO2002030944A3 (en) Fluorescent nucleobase conjugates having anionic linkers
DK0909183T3 (da) DHA-konjugerede farmaceutisk midler
EA199900598A1 (ru) Производные 1-арил- и пиридилпиразола с пестицидными свойствами
HN1998000168A (es) Derivados de la tienapirimidina y de la tienapiridina utiles como agentes anticancerigenos.
BR9812634A (pt) April - uma proteìna com efeitos de crescimento
DK276488A (da) Rekombinant pseudomonas exotoxin og opbygning af aktivt immunotoxin
BR0113162A (pt) Ariloxialquilaminas nao-imidazóis
DE60045847D1 (de) Rezeptorbindende konjugate
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
YU58599A (sh) Gelovi sa usporenim podržanim oslobađanjem
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
EP2962699A3 (de) Verbessertes verfahren zur herstellung von konjugaten von proteinen und chelatbildnern
DE69828080D1 (de) Pyrimidinderivate als markierte bindungspartner
BR9911978A (pt) Feniluracilas substituìdas
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
BR0110577A (pt) Decorina transgenicamente produzida
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
DK0557199T3 (da) Polyethylenglycol-hirudin-konjugater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af tromboser
DE60105647D1 (de) Pegylation von linker verbessert die antitumor-aktivität und verringert die toxizität von immunkonjugaten
BG100248A (bg) Инхибитори на скваленсинтетаза
DK0877631T3 (da) Konjugat af albumin og et xanthen-farvestof til differentiering mellem sygdomsramt og sundt væv

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee